| Dissecting muscle and neuronal disorders in a Drosophila model of muscular dystrophy HR Shcherbata, AS Yatsenko, L Patterson, VD Sood, U Nudel, D Yaffe, ... The EMBO journal 26 (2), 481-493, 2007 | 167 | 2007 |
| Recapitulation and design of protein binding peptide structures and sequences VD Sood, D Baker Journal of molecular biology 357 (3), 917-927, 2006 | 86 | 2006 |
| 4-thio-U cross-linking identifies the active site of the VS ribozyme SL Hiley, VD Sood, J Fan, RA Collins The EMBO journal 21 (17), 4691-4698, 2002 | 81 | 2002 |
| Balancing selectivity and efficacy of bispecific epidermal growth factor receptor (EGFR)× c-MET antibodies and antibody-drug conjugates C Sellmann, A Doerner, C Knuehl, N Rasche, V Sood, S Krah, L Rhiel, ... Journal of Biological Chemistry 291 (48), 25106-25119, 2016 | 74 | 2016 |
| Identification of phosphate groups involved in metal binding and tertiary interactions in the core of theNeurospora VS ribozyme VD Sood, TL Beattie, RA Collins Journal of molecular biology 282 (4), 741-750, 1998 | 73 | 1998 |
| Identification of the catalytic subdomain of the VS ribozyme and evidence for remarkable sequence tolerance in the active site loop VD Sood, RA Collins Journal of molecular biology 320 (3), 443-454, 2002 | 48 | 2002 |
| A New Enhancer of Position-Effect Variegation in Drosophila melanogaster Encodes a Putative RNA Helicase That Binds Chromosomes and Is Regulated by the … DF Eberl, LJ Lorenz, MB Melnick, V Sood, P Lasko, N Perrimon Genetics 146 (3), 951-963, 1997 | 45 | 1997 |
| Identification and characterization of M6903, an antagonistic anti–TIM-3 monoclonal antibody D Zhang, F Jiang, R Zaynagetdinov, H Huang, VD Sood, H Wang, X Zhao, ... Oncoimmunology 9 (1), 1744921, 2020 | 33 | 2020 |
| A putative Src homology 3 domain binding motif but not the C-terminal dystrophin WW domain binding motif is required for dystroglycan function in cellular polarity in Drosophila AS Yatsenko, EE Gray, HR Shcherbata, LB Patterson, VD Sood, ... Journal of Biological Chemistry 282 (20), 15159-15169, 2007 | 32 | 2007 |
| Epitope characterization of an anti‐PD‐L1 antibody using orthogonal approaches G Hao, JS Wesolowski, X Jiang, S Lauder, VD Sood Journal of Molecular Recognition 28 (4), 269-276, 2015 | 30 | 2015 |
| Identifying biophysical assays and in silico properties that enrich for slow clearance in clinical-stage therapeutic antibodies B Grinshpun, N Thorsteinson, JNS Pereira, F Rippmann, D Nannemann, ... MAbs 13 (1), 1932230, 2021 | 29 | 2021 |
| The contribution of 2′-hydroxyls to the cleavage activity of the Neurospora VS ribozyme VD Sood, S Yekta, RA Collins Nucleic acids research 30 (5), 1132-1138, 2002 | 25 | 2002 |
| Functional equivalence of the uridine turn and the hairpin as building blocks of tertiary structure in the Neurospora VS ribozyme VD Sood, RA Collins Journal of molecular biology 313 (5), 1013-1019, 2001 | 16 | 2001 |
| Colocalized targeting of TGF-β and PD-L1 by bintrafusp alfa elicits distinct antitumor responses Y Lan, TL Yeung, H Huang, AA Wegener, S Saha, M Toister-Achituv, ... Journal for ImmunoTherapy of Cancer 10 (7), 2022 | 10 | 2022 |
| SUMO: In Silico Sequence Assessment Using Multiple Optimization Parameters A Evers, S Malhotra, WG Bolick, A Najafian, M Borisovska, S Warszawski, ... Genotype Phenotype Coupling: Methods and Protocols, 383-398, 2023 | 6 | 2023 |
| Anti-PD-L1 antibodies and uses thereof HG Nastri, C Iffland, O Leger, Q An, M Cartwright, SD McKenna, VD Sood, ... US Patent 10,759,856, 2020 | 6 | 2020 |
| Anti-pd-l1 antibodies and uses thereof HG Nastri, C Iffland, O Leger, Q An, M Cartwright, SD Mckenna, VD Sood, ... SG Patent App. 11201402603W A, 2014 | 6 | 2014 |
| On the role of a conserved, potentially helix-breaking residue in the tRNA-binding α-helix of archaeal CCA-adding enzymes HD Cho, VD Sood, D Baker, AM Weiner RNA 14 (7), 1284-1289, 2008 | 3 | 2008 |
| Bi-specific antibodies for enhanced tumor selectivity and inhibition and uses thereof A Doerner, L Toleikis, VD Sood, C Sellmann, C Knuehl US Patent 11,235,063, 2022 | 2 | 2022 |
| Membrane proteins as targets for biological drugs VD Sood, AW Gross Advances in membrane proteins: building, signaling and malfunction, 49-65, 2019 | 2 | 2019 |
David BakerUniversity of WashingtonPotvrđena adresa e-pošte na uw.edu
